Published in Int J Biol Markers on August 03, 1999
Laparoscopic cholecystectomy: potential for missed pathology. Ann R Coll Surg Engl (1994) 3.03
Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res (2007) 1.97
MicroRNAs as Novel Biomarkers for Breast Cancer. J Oncol (2009) 1.72
Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin Cancer Res (2001) 1.69
Minimally invasive parathyroidectomy with operative ultrasound localization of the adenoma. Surg Endosc (2004) 1.58
Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg (2000) 1.58
Interns and their smartphones: use for clinical practice. Postgrad Med J (2013) 1.57
Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res (1999) 1.55
Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat (2010) 1.54
Authorship trends in the surgical literature. Br J Surg (2010) 1.52
Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer (1998) 1.51
Role of microRNAs in obesity and the metabolic syndrome. Obes Rev (2009) 1.47
Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res (1999) 1.41
A pilot project of European Working Time Directive compliant rosters in a university teaching hospital. Surgeon (2008) 1.40
Breast screening--a surgeon's perspective. Ir Med J (1993) 1.40
Pregnancy associated breast cancer. Ir Med J (2010) 1.39
Preparing new doctors for clinical practice: an evaluation of pre-internship training. Ir Med J (2013) 1.38
Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res (1998) 1.29
Endoscopic management of common duct stones with laparoscopic cholecystectomy. Ir J Med Sci (1991) 1.27
Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab (2011) 1.22
Postoperative fluid therapy--put not thy faith in dextrose saline: discussion paper. J R Soc Med (1991) 1.17
Optimal education techniques for basic surgical trainees: lessons from education theory. J R Coll Surg Edinb (1999) 1.13
Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol (1999) 1.13
Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg (2005) 1.12
Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol (2001) 1.11
Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer (2000) 1.10
Magnetic-resonance imaging for breast cancer. Lancet (1998) 1.08
Quality of life after immediate breast reconstruction and skin-sparing mastectomy - a comparison with patients undergoing breast conserving surgery. Eur J Surg Oncol (2011) 1.07
MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol (2011) 1.05
Breast reconstruction in the United Kingdom and Ireland. Br J Surg (2002) 1.05
Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort. Breast Cancer Res Treat (2009) 1.03
Systemic mirnas as potential biomarkers for malignancy. Int J Cancer (2012) 1.02
Circulating miR-34a levels are reduced in colorectal cancer. J Surg Oncol (2012) 1.00
Growth arrest-specific gene 6 expression in human breast cancer. Br J Cancer (2008) 1.00
Factors influencing medical students and junior doctors in choosing a career in surgery. Surgeon (2010) 0.99
MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol (2011) 0.98
An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma. Br J Cancer (1995) 0.98
Meralgia paraesthetica following laparoscopic inguinal hernia repair. An anatomical analysis. Surg Endosc (1995) 0.98
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries. Br J Surg (2010) 0.96
Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets? Hum Gene Ther (2010) 0.95
Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res (1998) 0.95
Gilmore's groin repair in athletes. J Orthop Sports Phys Ther (2000) 0.94
A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer. Eur J Surg Oncol (2007) 0.93
Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesions. Ann Surg (1999) 0.92
Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast. Int J Oncol (1999) 0.91
Unilateral breast masses in men over 40: a diagnostic dilemma. Am J Surg (1995) 0.91
Radial scars/complex sclerosing lesions and malignancy in a screening programme: incidence and histological features revisited. Histopathology (2007) 0.90
Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol (1998) 0.90
Genetic changes associated with telomerase activity in breast cancer. Int J Cancer (1999) 0.89
Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery? Br J Cancer (1998) 0.89
Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer. Eur J Cancer (2011) 0.85
17q12-21 - the pursuit of targeted therapy in breast cancer. Cancer Treat Rev (2010) 0.85
Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells. Int J Oncol (1999) 0.84
The role of sentinel lymph node biopsy in ductal carcinoma in situ. Eur J Surg Oncol (2005) 0.83
Primary small intestinal tumours: increased incidence of lymphoma and improved survival. Ann R Coll Surg Engl (1998) 0.83
The h index and the identification of global benchmarks for breast cancer research output. Breast Cancer Res Treat (2011) 0.82
Estrogen receptor beta and breast cancer. Eur J Surg Oncol (2004) 0.82
Conservative management of a desmoid tumour in pregnancy. J Obstet Gynaecol (2004) 0.82
The routine use of post-operative drains in thyroid surgery: an outdated concept. Ir Med J (2010) 0.82
Molecular profiling techniques and bioinformatics in cancer research. Eur J Surg Oncol (2006) 0.81
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer (2011) 0.81
Isolated resectable pancreatic metastasis 10 years post gastrectomy. Ir J Med Sci (2001) 0.81
A case of bilateral breast cancer with Peutz-Jeghers syndrome. Eur J Surg Oncol (2005) 0.81
Changing practices in the surgical management of hyperparathyroidism - a 10-year review. Surgeon (2011) 0.80
Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells. Br J Cancer (2000) 0.80
Cyclical ischaemic preconditioning modulates the adaptive immune response in human limb ischaemia-reperfusion injury. Br J Surg (2009) 0.80
Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? J Clin Pathol (2009) 0.80
Comparison of three methods for measuring cigarette smoking in patients with vascular disease. Cardiovasc Surg (1994) 0.79
Roles for the calcium sensing receptor in primary and metastatic cancer. Eur J Surg Oncol (2006) 0.79
Successful use of 'Epidrum' loss-of-resistance device for thoracic paravertebral blockade in patients undergoing breast cancer surgery: a case series. Eur J Anaesthesiol (2014) 0.79
Multicentricity and recurrence of breast cancer. Lancet (1997) 0.79
Graves' ophthalmopathy: the case for thyroid surgery. Surgeon (2009) 0.79
A prospective evaluation of CA15-3 in stage I carcinoma of the breast. J Am Coll Surg (1995) 0.78
Justifying adjuvant chemotherapy in breast cancer: a survey of women and healthcare professionals. Eur J Surg Oncol (2007) 0.78
Prognostic factors: guidelines for investigation design and state of the art analytical methods. Surg Oncol (1999) 0.78
Water-clear cell adenoma: A rare form of hyperparathyroidism. Int J Surg Case Rep (2013) 0.78
Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma. Br J Surg (2008) 0.78
In situ ESWL for ureteric calculi: the optimum treatment? Ir J Med Sci (1993) 0.78
Estrogen receptor alpha and beta profiling in human breast cancer. Eur J Surg Oncol (2004) 0.77
A study of pre-operative type and screen in breast surgery: improved efficiency and cost saving. Ir J Med Sci (2011) 0.76
Follow-up arrangements for breast cancer patients; is it appropriate to transfer surveillance to general practitioners? Ir Med J (2014) 0.76
Combined endoscopic cytology and biopsies in the diagnosis of duodenal malignancy. Br J Clin Pract (1990) 0.76
The significance of journal metrics for oral oncology. Oral Oncol (2009) 0.75
A review of sentinel lymph node biopsy for thin melanoma. Ir J Med Sci (2014) 0.75
Enlarging neck masses in the elderly - Histological and surgical considerations. Int J Surg Case Rep (2013) 0.75
Tissue polypeptide specific antigen (TPS) in breast cancer--an initial evaluation. Eur J Surg Oncol (1996) 0.75
The HER-2/neu story: from oncogene through prognostic marker to therapeutic strategy determinant and monoclonal therapy. Eur J Surg Oncol (1999) 0.75
The clinical and pathological differences in prevalent round screen-detected and symptomatic invasive breast cancer. Ir Med J (2007) 0.75
Oesophago-vascular fistulae secondary to benign peptic ulcer disease: a rare cause of fatal haemorrhage. Eur J Vasc Endovasc Surg (1995) 0.75
A comparison of surgical impression, histological findings and microbiological results at open appendicectomy. Ir Med J (2007) 0.75
Malignant phaeochromocytoma metastasising to the breast. Ir J Med Sci (2003) 0.75
Laparoscopic oophorectomy: a prospective evaluation in pre-menopausal breast cancer with particular reference to incidence and severity of menopausal symptoms. Eur J Surg Oncol (1996) 0.75
Surgical management of perforated peptic ulcer disease. Ir J Med Sci (2006) 0.75
Minimally invasive diagnosis and surgery in breast screening. Ir J Med Sci (1998) 0.75
Standards in Operation Notes--Is It Time to Re-Emphasise Their Importance? Ir Med J (2016) 0.75
The value of axillary lymphadenectomy. Eur J Surg Oncol (2003) 0.75
Laparoscopic oöphorectomy: description and report of an initial series. Br J Surg (1996) 0.75
Interactive multimedia information program for use by breast-care nurses--a patient acceptability study. Eur J Surg Oncol (1998) 0.75
NCCP breast cancer referral guidelines--are breast cancer patients prioritised? Ir Med J (2011) 0.75
Multiple cell populations in colorectal carcinomas: analysis by 3-colour fluorescence in situ hybridization. Int J Oncol (1998) 0.75